Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Hypersensitivity Reaction

  Free Subscription

Articles published in J Dermatol

Retrieve available abstracts of 132 articles:
HTML format

Single Articles

    February 2024
  1. YAZDANPARAST T, Nassiri Kashani M, Shamsipour M, Izadi Heidari F, et al
    Contact allergens responsible for eyelid dermatitis in adults.
    J Dermatol. 2024 Feb 13. doi: 10.1111/1346-8138.17140.
    PubMed     Abstract available

  2. TAKAMATSU N, Nakamura K, Suzuki M, Ito A, et al
    Food-dependent exercise-induced anaphylaxis caused by leek and several allergens of the allium family.
    J Dermatol. 2024 Feb 12. doi: 10.1111/1346-8138.17141.
    PubMed     Abstract available

  3. MUROTA H, Arima K, Yoshida T, Fujita H, et al
    Disease burden and treatment satisfaction in patients with prurigo nodularis in Japan.
    J Dermatol. 2024;51:223-233.
    PubMed     Abstract available

  4. ARAI Y, Okamura K, Saito T, Ito Y, et al
    A case of acute localized exanthematous pustulosis following COVID-19 infection.
    J Dermatol. 2024;51:e37-e38.

  5. YAMASHITA A, Fukui T, Akasaka E, Nakajima K, et al
    Acquired cutis laxa secondary to acute generalized exanthematous pustulosis: A case report and mini-review of literature.
    J Dermatol. 2024;51:287-293.
    PubMed     Abstract available

    January 2024
  6. SATOH TK, Neulinger MM, Stadler PC, Aoki R, et al
    Immune checkpoint inhibitor-induced epidermal necrolysis: A narrative review evaluating demographics, clinical features, and culprit medications.
    J Dermatol. 2024;51:3-11.
    PubMed     Abstract available

  7. CHEN L, Xu Q, Liu J, Li Z, et al
    Severe acute urticaria is associated with elevated plasma levels of D-dimer.
    J Dermatol. 2024;51:81-87.
    PubMed     Abstract available

    December 2023
  8. MASUDA T, Yonekura S, Kataoka K, Mizoguchi K, et al
    Psoriasis-like lesions in an atopic dermatitis patient possibly associated with nemolizumab treatment.
    J Dermatol. 2023 Dec 27. doi: 10.1111/1346-8138.17085.

    November 2023
  9. BOCHI-KURIMOTO M, Sakai T, Goto H, Miyazaki S, et al
    Management of severe allergy, reacting to acetaminophen and small doses of cyclooxygenase-2 inhibitor.
    J Dermatol. 2023 Nov 27. doi: 10.1111/1346-8138.17050.

  10. KANG DH, Kwon SH, Lew BL
    Four-year long-term drug survival of dupilumab analyzed by treatment period in patients with moderate to severe atopic dermatitis: A real-world retrospective study.
    J Dermatol. 2023 Nov 10. doi: 10.1111/1346-8138.17017.

  11. SUEHIRO M, Tanaka A
    A case of atopic dermatitis with self-healing acute diffuse and total alopecia during nemolizumab treatment.
    J Dermatol. 2023 Nov 6. doi: 10.1111/1346-8138.17023.

  12. TAKAMURA S, Nakamura K, Fukuda T
    Evaluation of the safety and effectiveness of berotralstat for patients with hereditary angioedema: Report of six cases.
    J Dermatol. 2023;50:1506-1508.

  13. HIDE M, Ohsawa I, Nurse C, Yu M, et al
    Efficacy and safety of lanadelumab in Japanese patients with hereditary angioedema: A phase 3 multicenter, open-label study.
    J Dermatol. 2023;50:1381-1391.
    PubMed     Abstract available

  14. HIDE M, Wang Y, Dote N, Miyakawa K, et al
    Safety, efficacy, and pharmacokinetics of icatibant treatment in Japanese pediatric patients with hereditary angioedema: A phase 3, open-label study.
    J Dermatol. 2023;50:1473-1477.
    PubMed     Abstract available

    October 2023
  15. ALEGRE-BAILO A, Sanchez-Gilo A, Marlene-Mendoza NM, Mateos-Rico JJ, et al
    Tralokinumab treatment in atopic dermatitis: Depicting super-responders.
    J Dermatol. 2023 Oct 23. doi: 10.1111/1346-8138.17009.

  16. SIMPSON EL, Kircik L, Blauvelt A, Kallender H, et al
    Clinically relevant improvements in adults and adolescents with atopic dermatitis who did not achieve Investigator's Global Assessment treatment success following 8 weeks of ruxolitinib cream monotherapy.
    J Dermatol. 2023 Oct 13. doi: 10.1111/1346-8138.16975.
    PubMed     Abstract available

  17. NAGASHIMA N, Ugajin T, Miyake K, Walls AF, et al
    Cutaneous basophil infiltration in atopic dermatitis is associated with abundant epidermal infiltration of helper T cells: A preliminary retrospective study.
    J Dermatol. 2023 Oct 3. doi: 10.1111/1346-8138.16987.
    PubMed     Abstract available

    September 2023
  18. NAKANE Y, Yoshikawa T, Takeichi T, Kono M, et al
    Dual clinical features of fine and rough scales seen in a combined ichthyosis vulgaris and X-linked recessive ichthyosis patient with atopic dermatitis.
    J Dermatol. 2023 Sep 21. doi: 10.1111/1346-8138.16968.

  19. KATSUTA M, Nobeyama Y, Hirafuku K, Tashiro K, et al
    Characteristics of mild and severe apalutamide-related cutaneous adverse events in patients with prostate cancer: A review of the literature.
    J Dermatol. 2023 Sep 21. doi: 10.1111/1346-8138.16972.
    PubMed     Abstract available

  20. HAGINO T, Yoshida M, Hamada R, Fujimoto E, et al
    Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with moderate-to-severe atopic dermatitis.
    J Dermatol. 2023 Sep 4. doi: 10.1111/1346-8138.16950.
    PubMed     Abstract available

  21. HIDA T, Ishikawa A, Okura M, Kishibe M, et al
    A Japanese patient with hereditary angioedema caused by deep intron variation in the SERPING1 gene.
    J Dermatol. 2023;50:e309-e310.

  22. TANAKA A, Fujimura Y, Fuke S, Izumi K, et al
    A case of bullous pemphigoid developing under treatment with benralizumab for bronchial asthma.
    J Dermatol. 2023;50:1199-1202.
    PubMed     Abstract available

    August 2023
  23. SAEKI H, Akiyama M, Abe M, Igarashi A, et al
    English version of Japanese guidance for biologics in treating atopic dermatitis.
    J Dermatol. 2023 Aug 31. doi: 10.1111/1346-8138.16932.
    PubMed     Abstract available

  24. SEISHIMA M, Sasaki M, Hachiken H, Furukawa T, et al
    Ulcerative colitis during dupilumab therapy in a patient with atopic dermatitis.
    J Dermatol. 2023 Aug 25. doi: 10.1111/1346-8138.16928.

  25. KOBAYASHI Y, Adachi T, Arakawa H, Minakata Y, et al
    A case of drug-induced hypersensitivity syndrome complicated with fulminant type 1 diabetes and type 2 myocardial infarction.
    J Dermatol. 2023 Aug 10. doi: 10.1111/1346-8138.16916.
    PubMed     Abstract available

  26. YANG X, Kong M, Wang H, Song Z, et al
    Symptomatic dermographism induced by oral minocycline: A report of four cases.
    J Dermatol. 2023;50:1063-1067.
    PubMed     Abstract available

    July 2023
  27. UCHIDA H, Kamata M, Watanabe A, Ito M, et al
    Improvement of severe alopecia areata after 9-month baricitinib treatment followed by subsequent use of upadacitinib in a patient with atopic dermatitis.
    J Dermatol. 2023 Jul 23. doi: 10.1111/1346-8138.16893.

  28. ISHIKAWA Y, Ajima S, Hashizume H
    Pityriasis rubra pilaris with simultaneous emergence of human herpesvirus-6 reactivation in a patient with drug-induced hypersensitivity syndrome.
    J Dermatol. 2023 Jul 19. doi: 10.1111/1346-8138.16877.

  29. MORIMOTO H, Oba M, Shirahama S, Tokura Y, et al
    Docetaxel-induced psoriasis with positive scratch patch test.
    J Dermatol. 2023 Jul 6. doi: 10.1111/1346-8138.16885.

  30. HAGIHARA E, Ito H, Okamoto T, Inomata N, et al
    A case of apple-dependent, exercise-induced anaphylaxis with sensitization to gibberellin-regulated proteins.
    J Dermatol. 2023 Jul 3. doi: 10.1111/1346-8138.16889.

  31. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
    Background factors predicting the occurrence of herpes zoster in atopic dermatitis patients treated with upadacitinib.
    J Dermatol. 2023 Jul 3. doi: 10.1111/1346-8138.16879.
    PubMed     Abstract available

  32. KAWAMURA H, Watanabe T, Yamamura H, Sano S, et al
    Post-orgasmic illness syndrome with positive intradermal test for autologous semen.
    J Dermatol. 2023;50:951-955.
    PubMed     Abstract available

    June 2023
  33. INOUE T, Watabe D, Akasaka K, Sasaki T, et al
    Refractory atopic dermatitis in a child with hypomorphic mutation in XIAP gene and low serum IgG.
    J Dermatol. 2023 Jun 19. doi: 10.1111/1346-8138.16869.

  34. NWIKUE G, Olsson-Brown A, Aboheimed N, Yip V, et al
    TNF-alpha induced extracellular release of keratinocyte high-mobility group box 1 in Stevens-Johnson syndrome/toxic epidermal necrolysis: Biomarker and putative mechanism of pathogenesis.
    J Dermatol. 2023 Jun 2. doi: 10.1111/1346-8138.16847.
    PubMed     Abstract available

  35. SUNAGAWA K, Manabe K, Hamada T
    Dermatofibrosarcoma protuberans coexisting with sarcoid reaction in a patient with sarcoidosis.
    J Dermatol. 2023;50:e194-e195.

  36. LEE JW, Yu DA, Cho S, Youn SW, et al
    Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series.
    J Dermatol. 2023;50:814-819.
    PubMed     Abstract available

  37. BARIT JJ, Hiroyasu S, Terashima Y, Ayano Y, et al
    Hereditary angioedema with normal C1 inhibitor with steroid responsiveness in a patient with psychiatric comorbidities.
    J Dermatol. 2023;50:e187-e188.

    May 2023
  38. HIRAI Y, Asada H, Hamada T, Kawada JI, et al
    Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy.
    J Dermatol. 2023 May 30. doi: 10.1111/1346-8138.16842.
    PubMed     Abstract available

  39. KWON IJ, Park JW, Kim SM, Lee KH, et al
    Allergen-specific immunotherapy improves alopecia totalis in a severe atopic dermatitis patient.
    J Dermatol. 2023 May 29. doi: 10.1111/1346-8138.16841.
    PubMed     Abstract available

  40. MA L, Zhang L, Kobayashi M, Tao X, et al
    Efficacy and safety of crisaborole ointment in Chinese and Japanese patients aged >/=2 years with mild-to-moderate atopic dermatitis.
    J Dermatol. 2023 May 8. doi: 10.1111/1346-8138.16792.
    PubMed     Abstract available

  41. TANAKA N, Nakatani S, Yahiro C, Takai T, et al
    Erythema multiforme associated with cancer radiotherapy: A single-institution case series and literature review.
    J Dermatol. 2023;50:656-663.
    PubMed     Abstract available

  42. IRAHARA M, Yamamoto-Hanada K, Sato M, Saito-Abe M, et al
    Endotoxin concentration and persistent eczema in early childhood.
    J Dermatol. 2023;50:646-655.
    PubMed     Abstract available

  43. KAWAKAMI T, Yokoyama K, Ikeda T, Nishibata Y, et al
    Similar deposition of neutrophil extracellular traps in the dermis among COVID-19-associated IgA vasculitis, post-COVID-19 vaccination IgA vasculitis, and COVID-19-unrelated IgA vasculitis.
    J Dermatol. 2023;50:e151-e152.

    April 2023
  44. KANAMOTO M, Takahagi S, Aoyama S, Kido Y, et al
    The expression of prolyl isomerase Pin1 is expanded in the skin of patients with atopic dermatitis and facilitates IL-33 expression in HaCaT cells.
    J Dermatol. 2023;50:462-471.
    PubMed     Abstract available

  45. ROH WS, Oh J, Lee MG, Kim TG, et al
    Elevated serum IgE levels are not associated with poor treatment outcome in psoriasis vulgaris.
    J Dermatol. 2023 Apr 1. doi: 10.1111/1346-8138.16795.
    PubMed     Abstract available

    March 2023
  46. TANG Z, Shen M, Man X
    Association between atopic dermatitis and hidradenitis suppurativa: A two-sample Mendelian randomization study.
    J Dermatol. 2023 Mar 29. doi: 10.1111/1346-8138.16796.

  47. NAPOLITANO M, Fabbrocini G, Patruno C
    Dupilumab-associated cutaneous adverse events among adult patients with atopic dermatitis: A retrospective study.
    J Dermatol. 2023 Mar 13. doi: 10.1111/1346-8138.16764.
    PubMed     Abstract available

  48. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
    Efficacy and safety of baricitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan.
    J Dermatol. 2023 Mar 8. doi: 10.1111/1346-8138.16763.
    PubMed     Abstract available

  49. WANG L, Wang Y, Wang XE, Chen B, et al
    Causal association between atopic eczema and inflammatory bowel disease: A two-sample bidirectional Mendelian randomization study of the East Asian population.
    J Dermatol. 2023;50:327-336.
    PubMed     Abstract available

  50. UESUGI-UCHIDA S, Fujisaki M, Sekine S, Takenao C, et al
    Non-episodic angioedema with eosinophilia developing after influenza vaccination: A case report.
    J Dermatol. 2023;50:e96-e97.

    February 2023
  51. TANAKA R, Kurihara Y, Egami S, Saito Y, et al
    Clinical severity scores as a guide for prediction of initial treatment responses in pemphigus and pemphigoid patients.
    J Dermatol. 2023;50:203-211.
    PubMed     Abstract available

    January 2023
  52. UEDA M, Kogame T, Egawa G, Kambe N, et al
    A case of Kimura disease with atopic dermatitis successfully treated with baricitinib.
    J Dermatol. 2023 Jan 20. doi: 10.1111/1346-8138.16724.

  53. NAKASHIMA C, Kato M, Otsuka A
    Cutaneous manifestations of COVID-19 and COVID-19 vaccination.
    J Dermatol. 2023 Jan 13. doi: 10.1111/1346-8138.16651.
    PubMed     Abstract available

    December 2022
  54. HAN J, Stratman S, Young JN, Poplausky D, et al
    Unique protein signatures evolve during the course of a delayed-type hypersensitivity reaction in human skin.
    J Dermatol. 2022 Dec 28. doi: 10.1111/1346-8138.16688.
    PubMed     Abstract available

  55. SUZUKI M, Koshikawa S, Watanabe H, Inomata N, et al
    Elevated serum osteopontin levels in patients with severe cutaneous adverse drug reactions.
    J Dermatol. 2022 Dec 20. doi: 10.1111/1346-8138.16670.
    PubMed     Abstract available

  56. LI J, Wen W, Mu Z, Du X, et al
    Prevalence of cutaneous manifestations in COVID-19: A meta-analysis.
    J Dermatol. 2022 Dec 20. doi: 10.1111/1346-8138.16672.
    PubMed     Abstract available

  57. ZHANG Z, Yu K, Jiang Z, Liu O, et al
    Clinical value of the prognostic nutritional index and red blood cell distribution width-to-albumin ratio for the prediction of severity of and mortality associated with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2022 Dec 7. doi: 10.1111/1346-8138.16661.
    PubMed     Abstract available

  58. NAKAGAWA Y, Chinuki Y, Ogino R, Yamasaki K, et al
    Cohort study of subclinical sensitization against galactose-alpha-1,3-galactose in Japan: Prevalence and regional variations.
    J Dermatol. 2022;49:1268-1277.
    PubMed     Abstract available

  59. SAITO R, Takahagi S, Nakano F, Furutani K, et al
    A survey on subtypes and clinical characteristics of 1061 patients with urticaria in the primary care institutes in Japan.
    J Dermatol. 2022;49:1255-1262.
    PubMed     Abstract available

  60. IKEDA T, Yokoyama K, Kawakami T
    Overlapping acute generalized exanthematous pustulosis drug reaction with eosinophilia and systemic symptoms induced by a second dose of the Moderna COVID-19 vaccine.
    J Dermatol. 2022;49:e446-e447.

    November 2022
  61. WATANABE T, Watanabe Y, Ikeda N, Aihara M, et al
    Serum levels of C-C motif chemokine ligand 2 and interleukin-8 as possible biomarkers in patients with toxic epidermal necrolysis accompanied by acute respiratory distress syndrome.
    J Dermatol. 2022 Nov 23. doi: 10.1111/1346-8138.16647.
    PubMed     Abstract available

  62. SAEKI H, Akiyama M, Abe M, Igarashi A, et al
    English version of Japanese guidance for the use of oral Janus kinase (JAK) inhibitors in the treatments of atopic dermatitis.
    J Dermatol. 2022 Nov 22. doi: 10.1111/1346-8138.16635.
    PubMed     Abstract available

  63. MIYAKE R, Iwamoto K, Sakai N, Matsunae K, et al
    Uptake of Staphylococcus aureus by keratinocytes is reduced by interferon-fibronectin pathway and filaggrin expression.
    J Dermatol. 2022;49:1148-1157.
    PubMed     Abstract available

  64. CHEN H, Zhang G, Zhang P, Long H, et al
    Case of borderline leprosy presenting with urticaria-like eruptions and limbs swelling: A lesson to be learned for dermatologists.
    J Dermatol. 2022;49:e409-e410.

    October 2022
  65. MIYAJI Y, Yamamoto-Hanada K, Fukuie T, Narita M, et al
    Risk factors of admission in school children with severe atopic dermatitis.
    J Dermatol. 2022 Oct 18. doi: 10.1111/1346-8138.16612.
    PubMed     Abstract available

    September 2022
  66. CHROMY D, Bartosik T, Brkic FF, Quint T, et al
    Dupilumab-induced skin-associated side effects in patients with chronic rhinosinusitis with nasal polyposis.
    J Dermatol. 2022 Sep 30. doi: 10.1111/1346-8138.16595.
    PubMed     Abstract available

  67. TOYODA T, Hashimoto K, Ogawa Y, Tohyama M, et al
    Immunohistological analysis of pathogenic infiltrates in the epidermis and liver of a patient with toxic epidermal necrolysis accompanied by vanishing bile duct syndrome.
    J Dermatol. 2022 Sep 29. doi: 10.1111/1346-8138.16576.
    PubMed     Abstract available

  68. MIYABE C, Oda T, Miyata R, Miyabe Y, et al
    Nephritis-associated plasmin receptor in the cutaneous vessels in IgA vasculitis.
    J Dermatol. 2022 Sep 24. doi: 10.1111/1346-8138.16574.

  69. LEE ES, Kiuchi Y, Inomata N, Sueki H, et al
    Increased expression of human herpes virus 6 receptor CD134/OX40 in skin lesions of patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16575.
    PubMed     Abstract available

  70. TANAKA A, Niimi N, Takahashi M, Takahashi H, et al
    Prevalence of skin diseases and prognosis of atopic dermatitis in primary school children in populated areas of Japan from 2010 to 2019: The Asa Study in Hiroshima, Japan.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16577.
    PubMed     Abstract available

  71. HATTORI N, Koike Y, Murota H
    Skin microbiome analysis in a case of atopic dermatitis induced by an interleukin 17 inhibitor used to treat psoriasis.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16586.

  72. FENG S, Song G, Liu L, Liu W, et al
    Allergen-specific immunotherapy induces monocyte-derived dendritic cells but attenuates their maturation and cytokine production in the lesional skin of an atopic dermatitis mouse model.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16582.
    PubMed     Abstract available

  73. MINAI L, Takeichi T, Ogawa Y, Honobe-Tabuchi A, et al
    Development of pemphigus vegetans and exacerbation of pemphigus foliaceus after secukinumab loading in a patient with complicated generalized pustular psoriasis and pyoderma gangrenosum.
    J Dermatol. 2022 Sep 2. doi: 10.1111/1346-8138.16563.
    PubMed     Abstract available

    August 2022
  74. SAEKI H, Ohya Y, Furuta J, Arakawa H, et al
    English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021.
    J Dermatol. 2022 Aug 22. doi: 10.1111/1346-8138.16527.
    PubMed     Abstract available

  75. HAGINO T, Saeki H, Kanda N
    The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan.
    J Dermatol. 2022 Aug 19. doi: 10.1111/1346-8138.16549.
    PubMed     Abstract available

  76. YAMASHITA A, Fukui T, Akasaka E, Nakajima K, et al
    A mild case of acute generalized exanthematous pustulosis caused by gemcitabine.
    J Dermatol. 2022;49:e261-e263.

    July 2022
  77. KAWAKAMI T, Nakade I, Tamura Y, Ito F, et al
    Typical cutaneous small-vessel vasculitis induced by combined injection of antiphosphatidylserine/prothrombin complex antibody and anti-LAMP-2 antibody in normal rats.
    J Dermatol. 2022 Jul 25. doi: 10.1111/1346-8138.16523.
    PubMed     Abstract available

  78. KAWAKAMI T, Yokoyama K, Ikeda T, Nishibata Y, et al
    Presence of neutrophil extracellular traps in superficial venous thrombosis of Behcet's disease.
    J Dermatol. 2022;49:741-745.
    PubMed     Abstract available

  79. KITAO R, Oda Y, Washio K, Tai Y, et al
    Lower efficacy of omalizumab in older adults with chronic spontaneous urticaria.
    J Dermatol. 2022;49:729-731.
    PubMed     Abstract available

    June 2022
  80. KATOH N, Saeki H, Kataoka Y, Etoh T, et al
    Evaluation of standard treatments for managing adult Japanese patients with inadequately controlled moderate-to-severe atopic dermatitis: Two-year data from the ADDRESS-J disease registry.
    J Dermatol. 2022 Jun 17. doi: 10.1111/1346-8138.16485.
    PubMed     Abstract available

  81. CHI MH, Chung WH, Hui RC, Chen CB, et al
    Clinical features and outcomes in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    J Dermatol. 2022 Jun 17. doi: 10.1111/1346-8138.16476.
    PubMed     Abstract available

  82. CHIANG CP, Hung CT, Chen YH, Chen CY, et al
    Stevens-Johnson syndrome and toxic epidermal necrolysis associated with increased risk of developing psychiatric disorders: A retrospective population-based cohort study in Taiwan.
    J Dermatol. 2022 Jun 10. doi: 10.1111/1346-8138.16487.
    PubMed     Abstract available

  83. YANAGIDA N, Takahagi S, Aoyama Y, Tanaka A, et al
    Anhidrosis accompanied by cholinergic urticaria-like rash and dermal pain in a patient with Sjogren's syndrome.
    J Dermatol. 2022;49:666-670.
    PubMed     Abstract available

    May 2022
  84. SALAVA A, Salo V, Remitz A
    Keratosis pilaris and filaggrin loss-of-function mutations in patients with atopic dermatitis - Results of a Finnish cross-sectional study.
    J Dermatol. 2022 May 26. doi: 10.1111/1346-8138.16477.
    PubMed     Abstract available

    Case of allergic contact dermatitis due to nickel contained in stainless steel skull pins.
    J Dermatol. 2022 May 3. doi: 10.1111/1346-8138.16421.

  86. TAKAMIYAGI S, Iriki H, Asahina Y, Furuichi Y, et al
    Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    J Dermatol. 2022 May 2. doi: 10.1111/1346-8138.16415.
    PubMed     Abstract available

  87. HASHIZUME H, Ajima S, Ishikawa Y
    Immunoglobulin A vasculitis post-severe acute respiratory syndrome coronavirus 2 vaccination and review of reported cases.
    J Dermatol. 2022;49:560-563.
    PubMed     Abstract available

    April 2022
  88. KIMURA H, Umemori Y, Yuki D
    Anaphylactic shock-like symptoms due to niacin overdose: A case report.
    J Dermatol. 2022 Apr 27. doi: 10.1111/1346-8138.16410.

  89. BOMZE D, Sprecher E, Geller S
    Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysis.
    J Dermatol. 2022 Apr 27. doi: 10.1111/1346-8138.16398.
    PubMed     Abstract available

  90. YU R, Chen S, Pan Y, Ma C, et al
    Combined use of cyclosporine in the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2022 Apr 19. doi: 10.1111/1346-8138.16369.
    PubMed     Abstract available

  91. KURIHARA K, Fujiyama T, Tokura Y, Honda T, et al
    Possible involvement of interleukin-22-producing CD103(+) CD8(+) T cells in the epidermal hyperplasia of atopic dermatitis.
    J Dermatol. 2022 Apr 1. doi: 10.1111/1346-8138.16382.

  92. GAMBICHLER T, Abu Rached N, Scholl L, Behle B, et al
    Reproducible leukocytoclastic vasculitis following severe acute respiratory syndrome coronavirus 2 vaccination.
    J Dermatol. 2022;49:145-146.

    March 2022
  93. KAN T, Tanaka A, Kanamoto M, Morioke S, et al
    Longitudinal prevalence of atopic dermatitis among freshmen at Hiroshima University between 2002 and 2019.
    J Dermatol. 2022 Mar 22. doi: 10.1111/1346-8138.16366.
    PubMed     Abstract available

  94. MAENO M, Tamagawa-Mineoka R, Arakawa Y, Masuda K, et al
    Facial discoid lupus erythematosus during dupilumab treatment for atopic dermatitis.
    J Dermatol. 2022 Mar 18. doi: 10.1111/1346-8138.16356.

  95. HE W, Hu X, Hua H, Li K, et al
    Allergic contact stomatitis due to desensitizing toothpastes.
    J Dermatol. 2022 Mar 8. doi: 10.1111/1346-8138.16338.
    PubMed     Abstract available

  96. MATSUSHIMA Y, Mizutani K, Iida S, Ichishi M, et al
    Severe skin inflammation leads to salivary gland atrophy and dysfunction.
    J Dermatol. 2022 Mar 7. doi: 10.1111/1346-8138.16334.
    PubMed     Abstract available

  97. UCHIYAMA A, Fujiwara C, Inoue Y, Motegi SI, et al
    Real-world effectiveness and safety of baricitinib in Japanese patients with atopic dermatitis: A single-center retrospective study.
    J Dermatol. 2022 Mar 6. doi: 10.1111/1346-8138.16350.

  98. LEE E, Lee S, Tashiro Y, Ogihara M, et al
    Sequential screening of biomarkers in a case of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms occurring with virus reactivation and autoimmune disease.
    J Dermatol. 2022 Mar 3. doi: 10.1111/1346-8138.16341.

  99. KOREKAWA A, Nakajima K, Fukushi K, Nakano H, et al
    Three cases of drug-induced hypersensitivity syndrome associated with mRNA-based coronavirus disease 2019 vaccines.
    J Dermatol. 2022 Mar 3. doi: 10.1111/1346-8138.16347.
    PubMed     Abstract available

  100. KONO T, Miyachi Y, Kawashima M
    Reply to Comment on "Clinical significance of the water retention and barrier function-improving capabilities of ceramide-containing formulations: A qualitative review".
    J Dermatol. 2022;49:e124.

    February 2022
  101. OKUNE M, Okiyama N, Fukuzono M, Sasaki K, et al
    Development of systemic lupus erythematosus after dupilumab treatment in a case of atopic dermatitis.
    J Dermatol. 2022 Feb 27. doi: 10.1111/1346-8138.16322.
    PubMed     Abstract available

  102. NAKAZAWA S, Phadungsakswasdi P, Kageyama H, Fukuchi K, et al
    Decreased serum level of suprabasin in patients with nickel allergy.
    J Dermatol. 2022 Feb 17. doi: 10.1111/1346-8138.16315.

  103. NISHIOKA K, Koizumi A, Takita Y
    Seven cases of contact dermatitis due to stearyl alcohol contained in topical medications.
    J Dermatol. 2022 Feb 16. doi: 10.1111/1346-8138.16325.
    PubMed     Abstract available

  104. HARADA K, Hagiwara T
    Gardner-Diamond syndrome complicated with chronic urticaria successfully treated with antihistamine.
    J Dermatol. 2022;49:e75-e76.

    January 2022
  105. HATTORI N, Koike Y, Murota H
    Treatment with an interleukin-17 inhibitor resulted in complete remission of psoriasis and flare-up of atopic dermatitis.
    J Dermatol. 2022 Jan 17. doi: 10.1111/1346-8138.16308.

  106. JEDLOWSKI PM, Jedlowski MF
    Coronavirus disease 2019-associated immunoglobulin A vasculitis/Henoch-Schonlein purpura: A case report and review.
    J Dermatol. 2022;49:190-196.
    PubMed     Abstract available

  107. JIN WJ, Ahn SW, Jang SH, Hong SM, et al
    Leukocytoclastic vasculitis after coronavirus disease 2019 vaccination.
    J Dermatol. 2022;49:e34-e35.

  108. OHATA M, Oda Y, Washio K, Fukunaga A, et al
    Efficacy of additional treatment for chronic spontaneous urticaria refractory to treatment - A single-center retrospective real-world study.
    J Dermatol. 2022;49:e7-e8.

    December 2021
  109. BABA A, Kanekura T, Tsubouchi H
    Lichenoid drug eruption after coronavirus disease 2019 vaccination.
    J Dermatol. 2021 Dec 27. doi: 10.1111/1346-8138.16294.

  110. INAZAWA-TERADA M, Namiki T, Omigawa C, Fujimoto T, et al
    An epidemiological survey of anhidrotic/hypohidrotic ectodermal dysplasia in Japan: High prevalence of allergic diseases.
    J Dermatol. 2021 Dec 13. doi: 10.1111/1346-8138.16278.
    PubMed     Abstract available

  111. HIRANO Y, Kosumi H, Miyazawa H, Yanagi T, et al
    Toxic epidermal necrolysis induced by tirabrutinib.
    J Dermatol. 2021 Dec 5. doi: 10.1111/1346-8138.16274.

  112. KONO T, Miyachi Y, Kawashima M
    Clinical significance of the water retention and barrier function-improving capabilities of ceramide-containing formulations: A qualitative review.
    J Dermatol. 2021;48:1807-1816.
    PubMed     Abstract available

  113. IWATA H, Kamiya K, Kado S, Nakaya T, et al
    Case of immunoglobulin A vasculitis following coronavirus disease 2019 vaccination.
    J Dermatol. 2021;48:e598-e599.

    November 2021
  114. MIYAGAWA A, Adachi T, Kobayashi Y, Takamiyagi S, et al
    Plasmapheresis as a promising treatment option in apalutamide-associated toxic epidermal necrolysis.
    J Dermatol. 2021 Nov 26. doi: 10.1111/1346-8138.16248.

  115. MATSUMOTO Y, Imamura S, Fukumoto A, Lee K, et al
    Case of oral mite anaphylaxis: Contamination of wheat flour by mites determined by enzyme-linked immunosorbent assay.
    J Dermatol. 2021 Nov 18. doi: 10.1111/1346-8138.16227.

  116. NAKAMURA R, Tanaka A, Kinoshita H, Ishii K, et al
    Minocycline-induced anaphylaxis mediated by antigen-specific immunoglobulin E.
    J Dermatol. 2021 Nov 9. doi: 10.1111/1346-8138.16228.

  117. HASHIZUME H, Ishikawa Y, Ajima S
    Is steroid pulse therapy a suitable treatment for drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms? A systematic review of case reports in patients treated with corticosteroids in Japan.
    J Dermatol. 2021 Nov 9. doi: 10.1111/1346-8138.16230.
    PubMed     Abstract available

  118. TOUBI E, Vadasz Z
    Predictive features associated with chronic spontaneous urticaria recurrence.
    J Dermatol. 2021;48:1786-1788.
    PubMed     Abstract available

  119. WU RW, Lin TK
    Oxford-AstraZeneca COVID-19 vaccine-induced acute localized exanthematous pustulosis.
    J Dermatol. 2021;48:e562-e563.

  120. MAURELLI M, Bellinato F, Girolomoni G
    Adrenergic urticaria successfully treated with omalizumab.
    J Dermatol. 2021;48:e541-e542.

  121. CHEN TL, Yip HT, Wang JH, Chang CH, et al
    Risk of chronic spontaneous urticaria in reproductive-aged women with abnormal uterine bleeding: A population-based cohort study.
    J Dermatol. 2021;48:1754-1762.
    PubMed     Abstract available

  122. OKU A, Nakai K, Ikenaga T, Sato K, et al
    Case of afatinib-induced severe purpuric drug eruption with gastrointestinal bleeding.
    J Dermatol. 2021;48:e534-e535.

    October 2021
  123. MIURA S, Moriyama T, Yoshimura J, Umehara K, et al
    Anaphylaxis to lipid transfer protein from butterbur scape.
    J Dermatol. 2021 Oct 29. doi: 10.1111/1346-8138.16213.

  124. SATO A, Takemori C, Fukumoto T, Aoyama N, et al
    Cutaneous leukocytoclastic vasculitis induced by thiamazole.
    J Dermatol. 2021 Oct 22. doi: 10.1111/1346-8138.16205.

  125. GOTO T, Kogure A, Kuwano Y
    Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with skin eruptions mimicking acute generalized exanthematous pustulosis.
    J Dermatol. 2021 Oct 8. doi: 10.1111/1346-8138.16190.

  126. KAGE P, Simon JC, Treudler R
    Case of atopic eczema treated with dupilumab throughout conception, pregnancy, and lactation.
    J Dermatol. 2021;48:E484-E485.

  127. KURIYAMA Y, Shimizu A, Oka H, Sato M, et al
    Erythema nodosum-like eruption in coronavirus disease 2019: A case report and literature review of Asian countries.
    J Dermatol. 2021;48:1588-1592.
    PubMed     Abstract available

  128. LIU KL, Tsai TL, Tsai WC, Tsai SF, et al
    Prenatal heavy metal exposure, total immunoglobulin E, trajectory, and atopic diseases: A 15-year follow-up study of a Taiwanese birth cohort.
    J Dermatol. 2021;48:1542-1549.
    PubMed     Abstract available

    September 2021
  129. HUANG HL, Xu HM, Liu YD, Shou DW, et al
    Fecal microbiota transplantation as a novel approach for the treatment of atopic dermatitis.
    J Dermatol. 2021 Sep 27. doi: 10.1111/1346-8138.16169.

  130. KIDO-NAKAHARA M, Yokote G, Yoshida M, Furue M, et al
    Atopic Dermatitis Control Tool (ADCT): A useful tool for self-evaluation in patients with atopic dermatitis.
    J Dermatol. 2021 Sep 27. doi: 10.1111/1346-8138.16176.

  131. ADACHI M, Adachi T, Yokota M, Ichimura C, et al
    A case of vancomycin-induced linear IgA bullous dermatosis with toxic epidermal necrolysis-like symptoms: Palmoplantar eruptions as a possible risk marker.
    J Dermatol. 2021 Sep 24. doi: 10.1111/1346-8138.16173.

    August 2021
  132. KAWANO N, Inoue H, Shiratori T
    Onset of Stevens-Johnson syndrome and toxic epidermal necrolysis overlap due to tirabrutinib.
    J Dermatol. 2021 Aug 4. doi: 10.1111/1346-8138.16093.

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.